During the past decade, Szent Imre Egyetemi Oktatokorhaz conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Szent Imre Egyetemi Oktatokorhaz" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Allergan" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Camurus AB" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Szent Imre Egyetemi Oktatokorhaz" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Szent Imre Egyetemi Oktatokorhaz" are "Breast Cancer" (3 trials), "Chronic Rhinosinusitis" (2 trials), "Macular Degeneration" (2 trials), "Nasal Polyps" (2 trials) and "Renal Impairment" (2 trials). Many other conditions were trialed in "Szent Imre Egyetemi Oktatokorhaz" in a lesser frequency.

Most popular intervention types in "Szent Imre Egyetemi Oktatokorhaz" are "Drug" (20 trials), "Biological" (4 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Bevacizumab" (2 trials), "Omalizumab" (2 trials), "Ranibizumab" (2 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Szent Imre Egyetemi Oktatokorhaz" are 20 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Szent Imre Egyetemi Oktatokorhaz". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Szent Imre Egyetemi Oktatokorhaz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Szent Imre Egyetemi Oktatokorhaz, 4 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Szent Imre Egyetemi Oktatokorhaz has several departments that took part in Clinical trials: "Szent Imre Egyetemi Oktatokorhaz, Klinikai Onkologiai Osztaly" - 2 trials